AU:PAR Stock Latest News
Company AnnouncementsParadigm Biopharmaceuticals Enters Administration After Phase 3 Trial Fails Futility Threshold2d ago
Company AnnouncementsParadigm Biopharmaceuticals Wins Extension for Key Creditors’ Meeting4d ago- Company AnnouncementsParadigm Administrators Seek Court Extension to Buy Time for Rescue Plan1w ago
Company AnnouncementsParadigm Biopharmaceuticals Redeems Convertible Notes Without Equity Conversion1w ago
Company AnnouncementsParadigm Biopharma Redeems Further Obsidian Convertible Notes Amid Administration1w ago
Company AnnouncementsParadigm Biopharmaceuticals Options Lapse, Simplifying Capital Structure1w agoCompany AnnouncementsParadigm Biopharmaceuticals Options to Expire Unexercised Amid Voluntary Administration2w ago
Company AnnouncementsParadigm Redeems More Convertible Notes and Flags Issues in Phase 3 Trial Data3w ago
Company AnnouncementsParadigm Biopharmaceuticals Shares Suspended as ASX Flags Financial Breach1M ago- Company AnnouncementsParadigm Biopharmaceuticals Enters Voluntary Administration1M ago
Company AnnouncementsParadigm Extends Trading Suspension Pending Phase 3 Data Review1M ago
Company AnnouncementsParadigm Biopharmaceuticals Cancels 2 Million Convertible Notes1M ago
Company AnnouncementsParadigm Biopharmaceuticals Halts Trading Ahead of Phase 3 Trial Update1M ago
Company AnnouncementsParadigm Biopharmaceuticals Seeks Quotation for 600,000 New ASX Shares1M ago
Company AnnouncementsParadigm Biopharmaceuticals reshapes medical leadership as Phase 3 osteoarthritis trial advances1M ago- Company AnnouncementsParadigm Biopharmaceuticals Lists Additional Shares on ASX1M ago
Company AnnouncementsParadigm Biopharmaceuticals issues cleansing notice for new convertible notes tranche1M agoCompany AnnouncementsParadigm Secures Further Funding as Knee Osteoarthritis Phase 3 Trial Fully Enrolled1M ago
